5 Beaten Down Yet Still Overpriced Stocks
These stocks have all lost more than 10% this year but continue to trade well above our fair value estimates.
Investors are told that the best time to buy is when there's "blood in the streets."
Five stocks that our analysts cover have, in fact, been bloodied this year: They're each more than 10% in the red as of this writing. Yet by our valuation metrics, they're still overpriced.
Susan Dziubinski does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.